Epilepsy, Generalized
Recurrent conditions characterized by epileptic seizures which arise diffusely and simultaneously from both hemispheres of the brain. Classification is generally based upon motor manifestations of the seizure (e.g., convulsive, nonconvulsive, akinetic, atonic, etc.) or etiology (e.g., idiopathic, cryptogenic, and symptomatic). (From Mayo Clin Proc, 1996 Apr;71(4):405-14)
Subtype terms (5)
More specific conditions that are subtypes of Epilepsy, Generalized in the MeSH hierarchy.
- Epilepsies, Myoclonic
17 drugs (7 approved, 10 experimental)
- Epilepsy, Absence
10 drugs (9 approved, 1 experimental)
- Epilepsy, Tonic-Clonic
6 drugs (5 approved, 1 experimental)
- Nodding Syndrome
4 drugs approved
- Spasms, Infantile
16 drugs (13 approved, 3 experimental)
Drugs by status
Approved for this indication (2)
Phase 4 trials (2)
Phase 3 trials (4)
Phase 2 trials (1)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (5)
Organization Involved with Phase 2 Indications (1)